Company: MDXG
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0001376339-25-000048
Chunk: 33

Company: MIMEDX GROUP, INC.
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 33
---
 the transaction did not involve a related party;

• whether there are demonstrable business reasons for the Company to enter into the transaction;

• whether the transaction would impair the independence of an outside director; and

• whether the transaction would present an improper conflict of interest for any director or executive officer, taking into account the size of the transaction, the direct or indirect nature of the related party’s interest in the transaction and the ongoing nature of any proposed relationship, and any other factors the Audit Committee deems relevant.

<div align='center'>16</div>

The Company maintains a written policy with respect to related party transactions. Based on information available to the Company and provided by the Company’s directors and executive officers, the Company does not believe that there have been any Related Party Transactions since January 1, 2024 that would be required to be disclosed as a Related Party Transaction pursuant to the applicable rules of the Securities and Exchange Commission and Nasdaq.

### EXECUTIVE COMPENSATION

#### Compensation Discussion and Analysis

#### Overview
This Compensation Discussion and Analysis provides an overview of the material components of our executive compensation philosophy and reviews the Company’s accomplishments and our compensation decisions for the following named executive officers ( “NEOs” ) for the fiscal year ended December 31, 2024:

• Joseph H. Capper (Chief Executive Officer since January 2023);

• Doug Rice (Chief Financial Officer since July 2023);

• William F. “Butch” Hulse IV (General Counsel and Chief Administrative Officer since April 2022; joined the Company as General Counsel and Secretary in December 2019);

• Ricci S. Whitlow (Executive Vice President and Chief Operating Officer since January 2023);

• Kimberly Maersk-Moller (Chief Commercial Officer since June 2024); joined the Company as Senior Vice President, Sales in August 2020.

The Compensation Committee (the “Committee” ) is responsible for evaluating and determining the compensation paid to the NEOs. All components of compensation for the NEOs are then recommended by the Committee to the Board for approval.

#### Summary Overview of 2024 Company Performance
Notes: Adjusted Gross Margin, Adjusted EBITDA and Free Cash Flow are non-GAAP financial measures. See Appendix A to this Proxy Statement for additional information regarding these measures, including reconciliations of such measures to their most directly comparable GAAP measure. Net cash balance is calculated as cash and cash equivalents less the sum of (i) current portion of long-term debt, and (